It sensitizes GBM cells to radiotherapy and TMZ both in vitro and in vivo, by reducing the activation of Akt, increasing the expression of pro-apoptotic proteins Bax and Caspase-3, and blocking radiation-induced DNA damage repair [146,150]. Here, AKT1 is linked to glioblastoma.